282 related articles for article (PubMed ID: 29642532)
1. Ursodeoxycholate Restores Biliary Excretion of Methotrexate in Rats with Ethinyl Estradiol Induced-Cholestasis by Restoring Canalicular Mrp2 Expression.
Kim MJ; Kang YJ; Kwon M; Choi YA; Choi MK; Chi HY; Yoo HH; Shim CK; Song IS
Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29642532
[TBL] [Abstract][Full Text] [Related]
2. Enhanced biliary excretion of canalicular membrane enzymes in ethynylestradiol-induced cholestasis. Effects of ursodeoxycholic acid administration.
Arrese M; Pizarro M; Solís N; Koenig C; Accatino L
Biochem Pharmacol; 1995 Oct; 50(8):1223-32. PubMed ID: 7488238
[TBL] [Abstract][Full Text] [Related]
3. Prevention of Mrp2 activity impairment in ethinylestradiol-induced cholestasis by ursodeoxycholate in the rat.
Crocenzi FA; D'Andrea V; Catania VA; Luquita MG; Pellegrino JM; Ochoa JE; Mottino AD; Sánchez Pozzi EJ
Drug Metab Dispos; 2005 Jul; 33(7):888-91. PubMed ID: 15843489
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of heme oxygenase induction in ethinylestradiol-induced cholestasis.
Muchova L; Vanova K; Suk J; Micuda S; Dolezelova E; Fuksa L; Cerny D; Farghali H; Zelenkova M; Lenicek M; Wong RJ; Vreman HJ; Vitek L
J Cell Mol Med; 2015 May; 19(5):924-33. PubMed ID: 25683492
[TBL] [Abstract][Full Text] [Related]
5. 3alpha-6alpha-Dihydroxy-7alpha-fluoro-5beta-cholanoate (UPF-680), physicochemical and physiological properties of a new fluorinated bile acid that prevents 17alpha-ethynyl-estradiol-induced cholestasis in rats.
Clerici C; Castellani D; Asciutti S; Pellicciari R; Setchell KD; O'Connell NC; Sadeghpour B; Camaioni E; Fiorucci S; Renga B; Nardi E; Sabatino G; Clementi M; Giuliano V; Baldoni M; Orlandi S; Mazzocchi A; Morelli A; Morelli O
Toxicol Appl Pharmacol; 2006 Jul; 214(2):199-208. PubMed ID: 16487557
[TBL] [Abstract][Full Text] [Related]
6. Effect of Ursodeoxycholic Acid on the Expression of the Hepatocellular Bile Acid Transporters (Ntcp and bsep) in Rats With Estrogen-Induced Cholestasis.
Micheline D; Emmanuel J; Serge E
J Pediatr Gastroenterol Nutr; 2002 Aug; 35(2):185-91. PubMed ID: 12187295
[TBL] [Abstract][Full Text] [Related]
7. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis.
Trauner M; Arrese M; Soroka CJ; Ananthanarayanan M; Koeppel TA; Schlosser SF; Suchy FJ; Keppler D; Boyer JL
Gastroenterology; 1997 Jul; 113(1):255-64. PubMed ID: 9207286
[TBL] [Abstract][Full Text] [Related]
8. Impaired activity of the bile canalicular organic anion transporter (Mrp2/cmoat) is not the main cause of ethinylestradiol-induced cholestasis in the rat.
Koopen NR; Wolters H; Havinga R; Vonk RJ; Jansen PL; Müller M; Kuipers F
Hepatology; 1998 Feb; 27(2):537-45. PubMed ID: 9462655
[TBL] [Abstract][Full Text] [Related]
9. Cholestatic effect of epigallocatechin gallate in rats is mediated via decreased expression of Mrp2.
Hirsova P; Karlasova G; Dolezelova E; Cermanova J; Zagorova M; Kadova Z; Hroch M; Sispera L; Tomsik P; Lenicek M; Vitek L; Pavek P; Kucera O; Cervinkova Z; Micuda S
Toxicology; 2013 Jan; 303():9-15. PubMed ID: 23146761
[TBL] [Abstract][Full Text] [Related]
10. UDCA and CDCA alleviate 17α-ethinylestradiol-induced cholestasis through PKA-AMPK pathways in rats.
Li X; Yuan Z; Liu R; Hassan HM; Yang H; Sun R; Zhang L; Jiang Z
Toxicol Appl Pharmacol; 2016 Nov; 311():12-25. PubMed ID: 27743861
[TBL] [Abstract][Full Text] [Related]
11. Anticholestatic mechanisms of ursodeoxycholic acid in lipopolysaccharide-induced cholestasis.
Razori MV; Maidagan PM; Ciriaci N; Andermatten RB; Barosso IR; Martín PL; Basiglio CL; Sánchez Pozzi EJ; Ruiz ML; Roma MG
Biochem Pharmacol; 2019 Oct; 168():48-56. PubMed ID: 31202734
[TBL] [Abstract][Full Text] [Related]
12. Beneficial effect of spironolactone administration on ethynylestradiol-induced cholestasis in the rat: involvement of up-regulation of multidrug resistance-associated protein 2.
Ruiz ML; Villanueva SS; Luquita MG; Ikushiro S; Mottino AD; Catania VA
Drug Metab Dispos; 2007 Nov; 35(11):2060-6. PubMed ID: 17686906
[TBL] [Abstract][Full Text] [Related]
13. Defective canalicular transport and toxicity of dietary ursodeoxycholic acid in the abcb11-/- mouse: transport and gene expression studies.
Wang R; Liu L; Sheps JA; Forrest D; Hofmann AF; Hagey LR; Ling V
Am J Physiol Gastrointest Liver Physiol; 2013 Aug; 305(4):G286-94. PubMed ID: 23764895
[TBL] [Abstract][Full Text] [Related]
14. Beneficial effects of colchicine on 17alpha-ethynylestradiol-induced cholestasis in rats.
Zhou ZX; Wang T; Jiang ZZ; Shang J; Liu L; Zhang Y; Zhu D; Huang X; Zhang S; Hu Y; Wang JY; Zhang LY
Arzneimittelforschung; 2011; 61(3):173-9. PubMed ID: 21528642
[TBL] [Abstract][Full Text] [Related]
15. Effects of ursodeoxycholic and cholic acid feeding on hepatocellular transporter expression in mouse liver.
Fickert P; Zollner G; Fuchsbichler A; Stumptner C; Pojer C; Zenz R; Lammert F; Stieger B; Meier PJ; Zatloukal K; Denk H; Trauner M
Gastroenterology; 2001 Jul; 121(1):170-83. PubMed ID: 11438506
[TBL] [Abstract][Full Text] [Related]
16. Alteration of the expression of adenosine triphosphate-binding cassette transporters associated with bile acid and cholesterol transport in the rat liver and intestine during cholestasis.
Kamisako T; Ogawa H
J Gastroenterol Hepatol; 2005 Sep; 20(9):1429-34. PubMed ID: 16105132
[TBL] [Abstract][Full Text] [Related]
17. Role of microtubules in estradiol-17beta-D-glucuronide-induced alteration of canalicular Mrp2 localization and activity.
Mottino AD; Crocenzi FA; Pozzi EJ; Veggi LM; Roma MG; Vore M
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G327-36. PubMed ID: 15374814
[TBL] [Abstract][Full Text] [Related]
18. Hepatic gene transfer of human aquaporin-1 improves bile salt secretory failure in rats with estrogen-induced cholestasis.
Marrone J; Soria LR; Danielli M; Lehmann GL; Larocca MC; Marinelli RA
Hepatology; 2016 Aug; 64(2):535-48. PubMed ID: 26999313
[TBL] [Abstract][Full Text] [Related]
19. Beneficial effect of Calculus Bovis Sativus on 17α-ethynylestradiol-induced cholestasis in the rat.
Liu D; Wu T; Zhang CL; Xu YJ; Chang MJ; Li XP; Cai HJ
Life Sci; 2014 Sep; 113(1-2):22-30. PubMed ID: 25072355
[TBL] [Abstract][Full Text] [Related]
20. Effects of 17α-ethynylestradiol-induced cholestasis on the pharmacokinetics of doxorubicin in rats: reduced biliary excretion and hepatic metabolism of doxorubicin.
Choi YH; Lee YK; Lee MG
Xenobiotica; 2013 Oct; 43(10):901-7. PubMed ID: 23574017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
